Manufactures pharmaceuticals

Cassiopea is clinical-stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products. Our initial focus is on the topical treatment of acne; androgenic alopecia, or AGA; and genital warts. These markets are characterized by a large patient population that is primarily served by a relatively small, and therefore accessible, number of treating physicians, principally dermatologists.

Ildong Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicines, ingredients for medicines, health supplements and special nutritional products. Its products include vitamins, antibiotics, gastric ulcer medicine, peptic ulcerative agents, and diet pills. The company was founded on August 1, 2016 and is headquartered in Seoul, South Korea.

Grindeks AS produces pharmaceutical, medical, and phytochemical medicine. It engages in the research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. The company specializes in the heart and cardiovascular, central nervous system, and anti-cancer medication therapeutic groups. Grindeks was founded in 1946 and is headquartered in Riga, Latvia.

McNeil-PPC, Inc. manufactures pharmaceutical and personal care products. The company was founded on December 30, 1988 and is headquartered in Fort Washington, PA.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of small molecule drugs. Its products include original medicine such as Chidamide, Chiglitazar, Chiauranib. It also engages in technological licensing. The company was founded by Xian Ping Lu and Zhi Qiang Ning on March 21, 2001 and is headquartered in Shenzhen, China.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Adamerck engages in the research and development of innovative drugs with independent intellectual property rights. The company has carried out more than 10 innovative drug research and development with independent intellectual property rights, all of which are urgently needed clinically and developed globally, with broad market prospects. These drugs are involved in anesthesia, cardiovascular and cerebrovascular, tumor, and other application fields.

Purac Biochem BV (doing business as Purac), part of Corbion NV, is a company headquartered in Gorinchem, the Netherlands. The firm develops and manufactures food preservatives, biobased chemicals and biopplastics.

Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Pierre Fabre Dermatologie SAS manufactures and markets products for skin diseases. It manages dermatological skin diseases such as acne. The company was founded in September 30, 1996 and is headquartered in Boulogne-Billancourt, France.

Aviara is the development of small molecule integrin inhibitors that modulate the activity of stem cells and inflammatory cells. Aviara’s lead clinical candidate, AVA4746, is being developed for the mobilization of hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with leukemia or lymphoma. In addition to AVA4746, Aviara is also developing a portfolio of small-molecule antagonists against a variety of integrin targets involved in the modulation of cell therapies and inflammatory disease such as minimal residual disease in cancer, cardiac stem cell transplant, dry eye disease and inflammatory bowel disease. Aviara has a collaboration with the Texas Heart Institute (THI) to explore the roles of integrins and other adhesion molecules in the development and trafficking of stem cells. Aviara and THI have entered into a joint discovery, development and cross-license agreement that provides access to THI research for the purpose of further development and commercialization.

Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, Innovation Center, and Corporate Activities. The Nutrition segment serves the global industries for animal feed, food and beverage, pharmaceuticals, infant nutrition, dietary supplements, and personal care. The Materials segment deals with specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. The Innovation Center segment focuses on innovation and the growth of DSM's existing core business through adjacent technologies. The Corporate Activities segment consists of operating and service activities as well as other several costs. The company was founded in 1902 and is headquartered in Herleen, the Netherlands.

Nanjing Heron Pharmaceutical Science & Technology Co., Ltd. principally engages in the research, development, production, and sale of drugs. The company was founded by Yang Chao on March 12, 2013 and is headquartered in Nanjing, China.